Rebecca Jacobson, MD
Dermatology · Framingham, MANPI 1336588136
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $3,000 of the $4,086 with a category attached, or 73.4%. Polynovo North America LLC accounts for 86.8% of it on its own, with 10 other manufacturers making up the rest. 2025 is the largest year on record at $4,037, more than ten times the $29 reported in 2021.
Across 16 payments — averaging $255.40 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Polynovo North America LLC$4K
- Revance Therapeutics, Inc.$198
- Medline Industries LP$80
- UCB, Inc.$59
- Regeneron Healthcare Solutions, Inc.$47
- Galderma Laboratories, L.p.$39
- plus $115 from 5 others
What the payments were for
- Consulting fees$3,00073%
- Travel & lodging$52613%
- Food & beverage$56114%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Polynovo North America LLC | 3 | $3,548 |
| Revance Therapeutics, Inc. | 1 | $198 |
| Medline Industries LP | 1 | $80 |
| UCB, Inc. | 2 | $59 |
| Regeneron Healthcare Solutions, Inc. | 1 | $47 |
| Galderma Laboratories, L.p. | 2 | $39 |
| Johnson & Johnson | 2 | $32 |
| LNHC, Inc | 1 | $29 |
| E.r. Squibb & Sons, L.L.C. | 1 | $20 |
| Mission Pharmacal Company | 1 | $17 |
| Verrica Pharmaceuticals Inc. | 1 | $17 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Novosorb BTM$3,526
- DAXXIFY$198
How this compares
$4,086 in reported general payments places this provider in the 70th percentile of 552 dermatology providers in Massachusetts.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Ketoconazole | 12 | $305 |
Paid to pharmacies, not to this prescriber.
Other dermatology in Framingham
- John HarrisWorcester$15M
- Ethan LernerCharlestown$1.7M
- Michael KaminerChestnut Hill$1.1M
- Jeffrey SobellChestnut Hill$986K
- Erik DominguesFall River$736K
- Alexandra KimballBoston$680K
- Arash MostaghimiBoston$591K
- David GreensteinBeverly$540K
- Brian HiblerBoston$498K
- Maryanne SennaBoston$430K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.